Therapeutic areas
Mucoprotection across gastroenterology, women’s health and proctology
Our scientific approach
Our portfolio is built on one scientific principle: protecting the mucosa. Rather than acting on the body's physiology, our products act mechanically, creating a protective barrier that helps the body restore its own function.
01 · Gastroenterology
Acute diarrhoea
Acute diarrhoea is one of the most common digestive conditions in children and adults. Our gastroenterology portfolio is built on mucoprotection, with products for adults and children.
The condition
Pathogens and their toxins adhere to the intestinal mucosa and alter its function. The gut loses more water than it absorbs, leading to frequent liquid or soft stools and abdominal discomfort.
How it acts
- Forms a protective film on the intestinal mucosa
- Limits the adhesion of pathogens, acting like the natural mucus
- Is not absorbed into the bloodstream
- Helps the body recover by itself
Highlights
- Clinical trialsRandomised controlled trials of xyloglucan in adults and of xyloglucan and gelose in children with acute diarrhoea
- Mode of actionExperimental study: gelatin tannate and xyloglucan form mucoadhesive films that limit toxin contact with the epithelium (Gastrointestinal Disorders, 2022)→
- GuidelinesOur mucoprotectants mentioned in the German guideline on acute infectious gastroenteritis in infants, children and adolescents (Z Gastroenterol, 2024)→
- CongressBarrier-based care for acute diarrhoea presented to paediatric gastroenterologists at ESPGHAN 2026, Lille→
02 · Women’s health
Uncomplicated urinary tract infections
Cystitis is frequent, especially in women, and often recurs. In the era of antibiotic resistance, we work on an antibiotic-sparing approach that starts in the gut.
The condition
Uropathogenic E. coli is the most common cause of urinary tract infections, and the bowel acts as its reservoir. From there, bacteria can proliferate and reach the urinary tract, which explains many recurrences.
How it acts
- Creates a protective barrier that helps prevent bacterial migration to the urinary tract
- Targets the intestinal bacterial reservoir behind new episodes
- Has no bactericidal or bacteriostatic properties, so it can be used alongside antibiotics when they are needed
Highlights
- GuidelinesMentioned in the European Association of Women’s health (EAU) guidelines as the non-antibiotic approach to cystitis with the highest level of scientific evidence
- GuidelinesUtipro® Plus mentioned by the Swiss Society of Gynecology and Obstetrics (SSGO) among antibiotic-free approaches for recurrent cystitis
- Meta-analysisSystematic review and meta-analysis of xyloglucan, hibiscus and propolis in uncomplicated lower urinary tract infections (Antibiotics)→
- Real-world studyUTISWISS: clinical practice study in 103 women in Switzerland with UTI-like symptoms (Uro)→
Related products
03 · Proctology
Anal fissures
An anal fissure is a tear in the lining of the anal canal. Our approach protects the lesion and modulates its environment, so the tissue can heal.
The condition
The lesion is exposed to friction, irritation and oxidative stress. These factors can keep it in the inflammatory phase and slow down the healing process.
How it acts
- Provides a scavenging effect towards free radicals
- Moisturises the wound
- Isolates and protects the lesion
- Mildly reduces the pH of the lesion
Highlights
- Clinical trialPilot open-label clinical trial of the EHO-85 hydrogel in anal fissures (Journal of Wound Management, 2024)→
- Clinical trialRandomised controlled trial of the EHO-85 hydrogel in hard-to-heal skin ulcers (J Clin Med, 2022)→
- Mode of actionExperimental studies on the antioxidant and wound-healing properties of olive leaf extract hydrogel→
Related products
Clinical data and dossiers
For more information, including clinical trial data and dossier details, please contact us.
This page provides general scientific information and does not replace professional medical advice.